Product image of Vyloy (Zolbetuximab) supplied by GNH India

Vyloy

Active Ingredient:
Zolbetuximab
Origin:
EU

Vyloy (Zolbetuximab)

Vyloy (zolbetuximab) is an intravenous therapy for certain gastrointestinal cancers. It targets claudin 18.2 proteins in tumor cells. This monoclonal antibody is prescribed for advanced gastric or gastroesophageal junction adenocarcinoma. Always consult a healthcare provider for suitability.

Manufacturer / TM Owner

Astellas Pharma Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vyloy is used to treat adults with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. It is indicated when tumors express claudin 18.2. This therapy is designed for patients whose cancer has not spread beyond initial treatment options. It is prescribed after confirming biomarker status with a diagnostic test.

Side Effects

  • As an intravenous infusion, Vyloy works by binding to claudin 18.2 proteins on cancer cells. This action helps the immune system recognize and target tumor cells. Patients may experience infusion-related reactions during administration. Common effects include fatigue, nausea, and vomiting.

Precautions & Warnings

  • Vyloy requires administration under medical supervision in a clinical setting. Patients should report any signs of infusion reactions immediately. Regular monitoring for dehydration and electrolyte imbalances is recommended. Healthcare providers will assess liver function before and during treatment.

Avoid Interactions

  • Vyloy may interact with medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers. Combining it with live vaccines is not advised during treatment. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they use. Alcohol consumption may increase side effects.

Frequently Asked Questions

Vyloy is used to treat advanced gastric or gastroesophageal junction adenocarcinoma in adults whose tumors express claudin 18.2.

Vyloy is given as an intravenous infusion in a healthcare setting, typically over several hours.

Common side effects include fatigue, nausea, vomiting, and infusion-related reactions.

Patients should discuss all medications with their doctor, as some may interact with Vyloy.

Vyloy is prescribed only for patients whose tumors express claudin 18.2, as confirmed by diagnostic testing.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zolbetuximab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT